2023 in review: A review of FDA approvals in eye care this year
December 15th 2023Eye care witnessed a transformative year with 11 FDA approvals. As the year concludes, there remains a robust pipeline of drugs, setting high expectations for continued advancements in ophthalmological care in 2024 and beyond.
FDA approves iDose TR from Glaukos for reduction of IOP in OAG or ocular hypertension
December 14th 2023iDose TR, a micro-invasive intraocular implant designed to lower IOP in patients with open-angle glaucoma or ocular hypertension, has received FDA approval following a new drug application (NDA) submission.